Successful First Edition of CPhI Russia Highlights Growth in Domestic Manufacturing and International Partnering

Amsterdam (ots/PRNewswire) -

Russian government's 'Pharma 2020 plan' to stimulate generics
growth and GMP production across the country

CPhI Russia reflected growth in the Russian Pharma market at its
debut next to IPhEB, the St Petersburg International Forum for
Pharmacy, Medical Equipment, Biotechnology and Radiology, and is the
latest addition to UBM Live's global pharmaceutical events portfolio.
The event was held at the Manege Central Exhibition Hall, St
Petersburg on 10th and 11th of April 2013 and brought together senior
Russian pharma professionals and international pharmaceutical
suppliers and buyers.

Following the event, the next few years are predicted to be a very
exciting time for investing in the region as the Russian
pharmaceutical market is now considered to be one of the most dynamic
in the world, and continues to grow at an average of 10-12% per year.
The country is already the eleventh largest pharmaceutical market and
is projected to reach a value of US $26.7 billion by the end of this
year. Furthermore, this tremendous growth is being achieved thanks to
the government support through its ambitious "Pharma 2020 Plan",
introduced in October 2009. The programme is aimed at achieving a
complex structural upgrade of the national pharmaceutical industry by
means of a substantial improvement in production capacity -
increasing both domestic and export production. The Plan, outlined
alongside other pharmaceutical innovations at the event, is currently
in its second stage and on course to achieve the following goals by
2017:

- Home production of national generics and achievement of medicines
independence of the Russian Federation
- Accreditation of all foreign producers of pharmaceutical substances and
official medicines entering the Russia market by the regulatory bodies in order to
strengthen quality control for official medicines
- Establishment of joint manufacturing and R&D structures with production sites
on the territory of Russia

Another Pharma 2020 project is the development of new, and the
modification of existing training programs, intended to provide the
pharma industry with employees capable of ensuring the transition to
international GMP standards.

"The Russian Government is making a big effort to keep the
pharmaceutical market attractive for international manufacturers in
order for them to fulfil their localisation plans" said Andrew Pert,
Brand Director for CPhI Russia. "The harmonisation with GMP is a
mandatory step for the Russian government and it has to be achieved
as soon as possible to enable the national market to be competitive
and to play an active role within the international pharmaceutical
market - but the growth potential in this region's industry should
not be under estimated and we envisage this event will expand
enormously over the coming years."

In addition to the exhibition, CPhI Russia presented an in-depth
conference programme that provided a comprehensive picture of the
Russian pharmaceutical market.

The plenary session, entitled "Pharmaceutical and Medical
Industries as Strategic areas of Innovative Economic Development"
focused on the Russian economic strategy in a rapidly growing
pharmaceutical market, particularly on how innovation and improved
GMP standards and harmonisation can stimulate rapid growth.
Furthermore, a debate on the International Cooperation in the area of
pharmaceuticals and biotechnology, followed by the successful
experiences of international pharmaceutical companies provided
unparalleled insights into how companies can enter and succeed in
this most dynamic of markets, including opportunities in the fast
developing generics and biosimilars market and the implications this
has for a regional regulatory framework.

Show Highlights

With 1,853 requests and 437 meetings conducted, the "Matchmaking
programme" was a huge success, allowing participants to arrange
one-to-one meetings with potential business partners prior to
attending the event via an automated meeting scheduler.

Additionally, the Gala Awards night for "Russian Leaders in the
Pharmaceutical and Biotechnology Industry", sponsored by Sotex Pharm,
took place during the opening ceremony. The awards were designed to
encourage the development of cutting-edge achievements in the field
of pharmaceutical, biotechnological and medical technologies and
winners included:

- OAO Phamasyntez - a leader in innovative TB drugs - for its 'contribution
to the development of innovative Russian products'
- OAO Akrikhin for its 'contribution to the modernisation of the pharma industry
in Russia'
- Regina Ilyasovna, general director of Invar pharmaceuticals, in the category
of 'effective business strategy' for developing successful business partnering
relations with a number of European pharmaceutical companies
- OJSC Biosintez for the 'development of export potential in the Russian
pharmaceutical industry' by meeting GMP requirements in order to improve the export
potential of Russian Pharmaceutical companies
- Indukern-Rus LLC, in the category of 'most reliable partner'

CPhI Russia 2014 expands to facilitate Pharma 2020 plan:

16th-17th April 2014, Lenexpo, St. Petersburg, Russia.

Russia's Pharma 2020 plan, which calls for 90% of medicines to be
locally produced by 2020, will require a substantial increase in the
country's entire pharmaceutical supply chain. In response to this, to
help provide a central hub for the growing demand, CPhI Russia 2014
will also launch four new co-located events:

- ICSE- connecting the pharmaceutical community with outsourcing solution
providers, offering a forum for business development, networking and education
- P-MEC- delivering innovative pharmaceutical machinery, equipment and
technology
- InnoPack- bringing together buyers and specifiers from the packaging and
pharmaceutical industries

MEDTEC Russia/iMeR - Leading suppliers of the international
medical manufacturing device industry

Notes for Editors

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. The flagship event, CPhI Worldwide is held in Europe, with
additional events in China, India, Japan, Southeast Asia, Russia and
South America co-located with ICSE for contract services, P-MEC for
equipment, InnoPack for packaging and BioPh for biopharma. CPhI
provides an online buyer & supplier directory at CPhI-Online.com and
hosts a global community with news and analysis at
PharmaEvolution.com, produced by UBM Live and partners.

For more information visit: http://www.cphi.com

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

About RESTEC(R) Exhibition Company:

RESTEC(R) Exhibition Company is one of the top three leaders of
the Russia`s exhibition business. The optimal structure formed by
RESTEC(R) let us combine exhibition, congress, business and contest
programs that altogether foster effective work of our exhibitors,
participants, delegates and trade visitors. At this point our
exhibition and congress events continue developing as centers of
international business networking with the constantly growing number
of countries and participants represented. For more information, go
to http://www.restec.ru/en

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6742
E: a.heeley@defacto.com t.jervis@defacto.com

Kirill Pakhryaev
Project manager
RESTEC(R) Exhibition Company, St. Petersburg,
Pakhryaev@restec.ru
Tel +7-(812)-303-88-67

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de